Eton Pharmaceuticals Names Judith Matthews CFO, Effective June 1
(RTTNews) - Eton Pharmaceuticals Inc. (ETON) on Thursday said it has appointed Judith M. Matthews as Executive Vice President, Accounting and Finance, effective immediately.
Matthews will assume the role of Chief Financial Officer on June 1, 2026, succeeding James Gruber, who will step down as part of a planned succession.
Matthews brings more than 25 years of finance leadership experience and previously served as Chief Financial Officer at Iterum Therapeutics plc from 2015 to 2026.
On Wednesday, Eton shares closed at $26.97, down 0.55%.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.